Related Experiment Video
Updated: Jun 12, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
The Brazilian experiment: HIV drugs for all
Paul J Flaer1, Mustafa Z Younis
1Stempel College of Public Health, Florida International University, Miami, Florida, USA.
Abstract:
The World Health Organization Joint Report of 2007 (WHO/UNAIDS/UNICEF) estimated that in developing world economies, 2 million people with HIV/AIDS were being treated with antiretroviral drugs (ARVs) out of the 7 million needing treatment. The ongoing political and humanistic movement in Brazil highly relates to health care provision, especially to treatment of the HIV/AIDS epidemic. "Compulsory licensing" (patent breaking) was used by Brazil to manufacture and import HIV/AIDS drugs. The Brazilian government provided top-of-the-line antiretroviral drugs in the form of HAART (highly active antiretroviral therapy) to all needing treatment for HIV/AIDS. Subsequently, the international community found Brazil as an eager "poster child" in the universal access movement for HIV/AIDS drugs. However, can this program of justice and humanity in Brazil be feasible when applied to the HIV/AIDS epidemic in other developing world countries? It is worth exploring.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Retroviruses
Drug Therapy
Antianxiety Medications
Subviral Agents
Treatment Resistent Cancers

